Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
35.83
+0.57 (1.62%)
Aug 13, 2025, 3:00 PM - Market open
Paramount Global Market Cap
Revolution Medicines has a market cap or net worth of $6.70 billion as of August 13, 2025. Its market cap has decreased by -12.58% in one year.
Market Cap
6.70B
Enterprise Value
4.68B
1-Year Change
-12.58%
Ranking
Category
Stock Price
$35.83
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $6.70B, an increase of 307.29%. That is a compound annual growth rate of 29.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 6.59B | -18.45% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |